Camber Pharmaceuticals supplier risk assessment Q1 2026 – India sourcing profile, compliance status, and tier-2 supplier analysis.
Camber Pharmaceuticals processed 97 shipments in Q1 2026 across 4 suppliers, all sourced from India. India accounts for 100% of the importer's trade footprint. The company's top suppliers are Hetero Labs with 59 shipments and Annora Pharma Private with 22 shipments. HS chapter data was not available for this shipment set.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
Camber Pharmaceuticals registered no sanctions watchlist matches in Q1 2026. No suppliers showed forced-labor exposure flags under UFLPA proximity screening.
4 distinct tier-1 suppliers in Q1 2026
| HETERO LABS | India | 59 |
| ANNORA PHARMA PRIVATE | India | 22 |
| ASPIRO PHARMA | India | 14 |
| ANNORA PHARMA | India | 2 |
Share of Q1 2026 inbound shipments by source country
4 tier-2 + 4 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.